Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Visual Spatial Exploration and Art Therapy Intervention in Patients Diagnosed With Parkinson's Disease

Trial N/A Completed March 20, 2022

Effects of Routine Physical Therapy With and Without Proprioceptive Neuromuscular Facilitation on Balance, Gait and Function in Patients With Parkinson's Disease

Trial N/A Completed March 17, 2022

Assessment of Transcranial Electrical Stimulation and Auditory Stimulation During Walking in Parkinson Patients

Trial N/A Unknown March 17, 2022

Finding the Right Words in Neurogenic Communication Disorders

Trial N/A Completed March 15, 2022

Use and Misuse of Domperidone in Parkinson's Disease in France - Observational

Trial N/A Terminated March 14, 2022

Lifestyle and Non-motor Symptom Management in Parkinson's Disease

Trial N/A Terminated March 10, 2022

Cannabis Oil for Pain in Parkinson's Disease

Trial Phase 2 Unknown March 9, 2022

Assessment of Empathetic Process by Scanpath Study of an Artwork

Trial N/A Completed March 8, 2022

Role of Sleep on Motor Learning in Parkinson's Disease and Healthy Older Adults

Trial N/A Unknown March 8, 2022

A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease Patients

Trial Phase 3 Completed March 1, 2022

A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease Participants

Trial Phase 3 Completed March 1, 2022

Safety and Efficacy of Droxidopa for Fatigue in Patients With Parkinsonism

Trial Phase 2 Withdrawn March 1, 2022

A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease Participants

Trial Phase 3 Completed March 1, 2022

A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease Participants

Trial Phase 2 Completed March 1, 2022

Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease

Trial Phase 2 Terminated Feb. 27, 2022

Cognitive-driven ADL Impairment as a Predictor for PDD

Trial N/A Completed Feb. 23, 2022

Investigation of Gait, Foot Pressure Distribution and Balance in Parkinson's Patients With Motor Freezing

Trial N/A Completed Feb. 21, 2022

Assessment of Fluctuating Parkinson's Disease With Sensor-based Home Monitoring

Trial N/A Completed Feb. 17, 2022

Compensation Mechanisms in Parkinson's Disease

Trial N/A Completed Feb. 17, 2022

Systematic Follow up of Second Line Treatments for Parkinson's Disease (Deep Brain Stimulation, Apomorphin Pump, Duodopa Pump)

Trial N/A Not yet recruiting Feb. 16, 2022